Showing results (161-170 of 321) with videos related to
Sort By:
Pageof 33
Frontiers in Pediatrics|October 5, 2020
Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE SyndromeMark J Ponsford, James Clark, Joel Mock, et al.Plos One|November 9, 2013
Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide geneHong Zhan, Kimberly Gilmour, Lucas Chan, et al.Haematologica|July 11, 2024
Umbilical cord blood T cells can be isolated and enriched by CD62L selection for use in 'off the shelf' chimeric antigen receptor T-cell therapies to widen transplant optionsChristos Georgiadis, Lauren Nickolay, Farhatullah Syed, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2018
Long Terminal Repeat CRISPR-CAR-Coupled "Universal" T Cells Mediate Potent Anti-leukemic EffectsChristos Georgiadis, Roland Preece, Lauren Nickolay, et al.Plos One|August 23, 2014
Accuracy of the interpretation of chest radiographs for the diagnosis of paediatric pneumoniaMohamed A Elemraid, Michelle Muller, David A Spencer, et al.Current Opinion in Immunology|July 31, 2012
The role of induced pluripotent stem cells in research and therapy of primary immunodeficienciesKatja G Weinacht, Patrick M Brauer, Kerstin Felgentreff, et al.Communications Biology|July 16, 2020
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cellsRebeca Arroyo Hornero, Christos Georgiadis, Peng Hua, et al.Journal of Clinical Immunology|March 17, 2023
Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of ImmunityZainab M Golwala, Nikita Gireesh Bhat, Jinhua Xu-Bayford, et al.Journal of Clinical Immunology|March 19, 2022
TCRαβ-Depleted Haploidentical Grafts Are a Safe Alternative to HLA-Matched Unrelated Donor Stem Cell Transplants for Infants with Severe Combined ImmunodeficiencyChristo Tsilifis, Su Han Lum, Zohreh Nademi, et al.The Journal of Allergy and Clinical Immunology|December 19, 2007
Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiencyMary A Slatter, Kenneth Brigham, Anne M Dickinson, et al.Pageof 33